- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01490281
Exercise in Women With Fibromyalgia
Land- and Water-Based Exercise Intervention in Women With Fibromyalgia: The Al-Andalus Physical Activity Randomised Control Trial
Background The Al-Andalus physical activity intervention study is a randomised control trial to investigate the effectiveness of a land- and water-based exercise intervention for reducing the overall impact of fibromyalgia (primary outcome), and for improving tenderness and pain-related measures, body composition, functional capacity, physical activity and sedentary behaviour, fatigue, sleep quality, health-related quality of life, and cognitive function (secondary outcomes) in women with fibromyalgia.
Methods One hundred eighty women with fibromyalgia (age range: 35-65 years) will be recruited from local associations of fibromyalgia patients in Andalucía (Southern Spain). Patients will be randomly assigned to a usual care (control) group (n=60), a water-based exercise intervention group (n=60) or a land-based exercise intervention group (n=60). Participants in the usual care group will receive general physical activity guidelines and participants allocated in the intervention groups will attend three non-consecutive training sessions (60 minutes each) per week during 24 weeks. Both exercise interventions will consist of aerobic, muscular strength and flexibility exercises.
Discussion The investigators study attempts to reduce the impact of fibromyalgia and improve patients' health status by implementing two types of exercise interventions. Results from this study will help to assess the efficacy of exercise interventions for the treatment of fibromyalgia. If the interventions would be effective, this study will provide low-cost and feasible alternatives for health professionals in the management of fibromyalgia. Results from the Al-Andalus physical activity intervention will help to better understand the potential of regular physical activity for improving the well-being of women with fibromyalgia.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Phase 2
Contacts and Locations
Study Locations
-
-
-
Granada, Spain, 18011
- University of Granada
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age: 35-65 years.
- Meeting the American College of Rheumatology criteria: widespread pain for more than 3 months, and pain with 4 kg/cm of pressure reported for 11 or more of 18 tender points.
- Not to have other severe somatic or psychiatric disorders, or other diseases that prevent physical loading (Answer "no" to all questions on the Physical Activity Readiness Questionnaire-PAR-Q ).
- Not to be engaged in regular physical activity >20 minutes on >3 days/week.
- Planning to stay in the same Association during the study.
- Able to ambulate, with or without assistance.
- Able to communicate.
- Informed consent: Must be capable and willing to provide consent.
Exclusion Criteria:
- Acute or terminal illness.
- Myocardial infarction in the past 3 months.
- Not capable to ambulate.
- Unstable cardiovascular disease or other medical condition.
- Upper or lower extremity fracture in the past 3 months.
- Severe dementia (MMSE<10).
- Unwillingness to either complete the study requirements or to be randomised into control or training group.
- Presence of neuromuscular disease or drugs affecting neuromuscular function.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: FACTORIAL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
NO_INTERVENTION: Control group
|
|
|
EXPERIMENTAL: water-based exercise intervention
|
Interventions will consist of aerobic, muscular strength and flexibility exercises in the water
|
|
EXPERIMENTAL: land-based exercise intervention
|
Interventions will consist of aerobic, muscular strength and flexibility exercises in the land
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall impact of fibromyalgia
Time Frame: Participants will be followed over 24 weeks
|
The primary outcome will be assessed with the fibromyalgia Impact Questionnaire (FIQ).
FIQ is a self-administered questionnaire, comprising 10 subscales of disabilities and symptoms (physical function, work missed day, job ability, feel good, pain, fatigue, sleep, stiffness, anxiety and depression) and has been validated for Spanish fibromyalgia patients.
The total scores range from 0 to 100, with a higher score indicating greater effect of the condition on the person's life.
|
Participants will be followed over 24 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tenderness
Time Frame: Participants will be followed over 24 weeks
|
A total of 18 tender points will be assessed according to the American College of Rheumatology criteria for classification of fibromyalgia using a standard pressure algometer (FPK 20; Effegi, Alfonsine, Italy).
The tender point count, total count of positive tender points, will be recorded for each participant.
The algometer score will be calculated as the sum of the minimum pain-pressure values obtained for each tender point.
|
Participants will be followed over 24 weeks
|
|
Visual analogic scale for pain
Time Frame: Participants will be followed over 24 weeks
|
Visual analogic scale for pain.
This is a simple assessment tool consisting of a 10 cm line with 0 on one end, representing no pain, and 10 on the other, representing the worst pain ever experienced, which a patient marks to indicate the severity of her pain in the present moment.
This scale will also be administered before and after each session during the intervention, to assess the acute effect of exercise on pain.
|
Participants will be followed over 24 weeks
|
|
The Pain Catastrophizing Scale
Time Frame: Participants will be followed over 24 weeks
|
It assesses three factors: rumination, magnification and helplessness associated to pain.
It includes 13 items measured on a 5-point Likert scale ranging from 0 (not at all) to 4 (all the time).
Higher scores indicate a greater tendency to catastrophize pain symptoms.
|
Participants will be followed over 24 weeks
|
|
Body composition
Time Frame: Participants will be followed over 24 weeks
|
Weight and height will be measured, body mass index [weight (kg)/height(m2)] will be calculated, and skeletal muscle mass, total body water and fat free mass will be estimated with bioelectrical impedance analysis (InBody R20; Biospace, Gateshead, UK).
|
Participants will be followed over 24 weeks
|
|
Functional capacity
Time Frame: Participants will be followed over 24 weeks
|
Participants' functional capacity will be assessed by field-based fitness tests following the standardised Functional Senior Fitness Test Battery
|
Participants will be followed over 24 weeks
|
|
Fatigue
Time Frame: Participants will be followed over 24 weeks
|
The Multidimensional Fatigue Inventory will be used to measure fatigue severity, and comprises five subscales: general fatigue, physical fatigue, mental fatigue, reduced activity, and reduced motivation.
|
Participants will be followed over 24 weeks
|
|
Sleep Quality
Time Frame: Participants will be followed over 24 weeks
|
Pittsburgh Sleep Quality Index will be used to assess sleep quality and disturbances
|
Participants will be followed over 24 weeks
|
|
Health-related quality of life
Time Frame: Participants will be followed over 24 weeks
|
We will determine patients' quality of life with the Short-Form Health Survey 36 (SF-36)
|
Participants will be followed over 24 weeks
|
|
Cognitive function
Time Frame: Participants will be followed over 24 weeks
|
The Mini Mental State Examination (MMSE) will be used to evaluate cognitive capacity and severity of dementia for the exclusion criteria
|
Participants will be followed over 24 weeks
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- DEP2010-15639
- CTCD-201000019242-TRA (OTHER_GRANT: CTCD-201000019242-TRA)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fibromyalgia
-
Ionclinics & Deionic SLHospital Clínico Universitario de ValenciaNot yet recruitingFibromyalgia (FM)Spain
-
Ain Shams UniversityRecruiting
-
Selcuk UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...CompletedFibromyalgia (FM)Spain
-
Istanbul Gelisim UniversityBahçeşehir UniversityCompleted
-
Gazi UniversityCompletedFibromyalgia SyndromeTurkey (Türkiye)
-
University of UtahRecruitingFibromyalgia (FM)United States
-
María Catalina Osuna PérezActive, not recruitingFibromyalgia SyndromeSpain
-
Istanbul UniversityCompletedFibromyalgia | Fibromyalgia Syndrome | Fibromyalgia (FM)Turkey (Türkiye)
Clinical Trials on water-based exercise
-
Mariano Marcos State UniversityCompleted
-
Józef Piłsudski University of Physical EducationUniversity of Sydney; Polish National Agency for Academic ExchangeCompletedCOVID-19 | Quality of Life | Children, Only | Lung Function DecreasedPoland
-
University of BradfordSt George's University Hospitals NHS Foundation TrustCompletedPregnancy Related | Pelvic Girdle PainUnited Kingdom
-
Chulalongkorn UniversityCompleted
-
University Medical Centre LjubljanaKRKACompletedCoronary Artery DiseaseSlovenia
-
Universidade Metodista de PiracicabaCompletedArteriosclerosis, CoronaryBrazil
-
Istanbul Medipol University HospitalNot yet recruiting
-
Universidade Metodista de PiracicabaUnknownArteriosclerosis, CoronaryBrazil
-
Universidade Estadual Paulista Júlio de Mesquita...Fundação de Amparo à Pesquisa do Estado de São PauloRecruiting